DNAGOTCHealthcare · Biotechnology

DNAPrint Genomics, Inc.

$0.00+0.00%(+$0.00)

TickerSpark Score

76/100

Solid

100

Valuation

Profitability

100

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNAG research report →

52-Week Range100% of range

Low $0.00

Current $0.00

High $0.00

Companywww.dnaprint.com

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents.

CEO: Jatin Patel
IPO: 2001
Employees: 24
HQ: Sarasota, US

Price Chart

+0.00% · this period

Valuation

Market Cap: $12.89K
P/E: -0.00
P/S: 0.01
P/B: -0.00
EV/EBITDA: -0.75
Div Yield: 0.00%

Profitability

Gross Margin: 30.99%
Op Margin: -364.45%
Net Margin: -507.54%
ROE: 316.59%
ROIC: 0.00%

Growth & Income

Revenue: $2.43M · 90.75%
Net Income: $-12,348,364 · -41.68%
EPS: $-0.03 · 66.67%
Op Income: $-8,867,169
FCF YoY: -65.53%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: 1.53
Avg Volume: 27

Get TickerSpark's AI analysis on DNAG

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime